Ama­zon sub­sidiary Pill­Pack reach­es a set­tle­ment with US gov­ern­ment and will have to shell out over $5.6M

Ama­zon’s on­line phar­ma­cy has set­tled a law­suit in New York af­ter al­le­ga­tions of over­billing for the life­sav­ing drug in­sulin.

The set­tle­ment re­solves al­le­ga­tions that the phar­ma­cy, known as Pill­Pack, im­prop­er­ly billed gov­ern­ment health­care pro­grams like Medicare and Med­ic­aid for more in­sulin pens than pa­tients need­ed ac­cord­ing to their pre­scrip­tions, and for false­ly un­der-re­port­ing the days in­sulin sup­plies were dis­pensed.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER